A US man spoke yesterday of his happiness at the prospect of touching his young grandchildren for the first time, following a rare double hand transplant at a Boston hospital.

Richard Mangino, 65, lost his arms below the elbows and his lower legs from an infection in 2002. After a 12-hour operation by a 40-strong surgical team at Brigham and Women’s Hospital – best known for pioneering face transplants – he got donated hands.

In his first remarks, he thanked the family of the donor. But Mr Mangino said his main emotion now was happiness at the prospect of regaining a more normal life and, above all, the ability to play with his grandchildren.

“The one miracle I have prayed for, since my oldest grandson Trevor was born, was to be able to feel the sense of touch again. To touch his and Nicky’s little faces, and stroke their hair, and to teach them to throw a ball. To me, that would be a miracle,” he said in the statement.

“And today, my miracle has come true. And I am eternally grateful.”

The father of three had until now used prosthetic limbs and had some success in living a normal existence, reportedly driving a car, playing guitar and using a computer.

However, those achievements were not easily managed. He told thebostonchannel.com that the loss of one limb requires a person to use a quarter to a third more energy.The transplant involved delicate connection of skin, tendons, muscles, ligaments, bones and blood vessels.

Only 21 double hand transplants have previously been made around the world, with the first in the French city of Lyon in 2000, according to the International Registry on Hand and Composite Tissue Transplantation.

Simon Talbot, the lead surgeon, told MSNBC television that “the results so far have been an amazing success.”

However, Mr Mangino needs months of therapy and it will take at least half a year for him to regain a sense of touch, the surgeon said.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.